Jennifer Gold

Jennifer Gold

Tuesday, 27 October 2009 00:00

Don't Share Insulin Pens Between Patients

FDA is reminding health care professionals not to use a single insulin pen and cartridge on more than one patient. Even if needles are changed between patients, reusing these products on multiple patients may transmit blood-borne pathogens such as hepatitis or HIV between patients.


Wednesday, 27 June 2012 16:20

Site Accessibility


This website is committed to ensuring accessible to all users.

eSSENTIAL Accessibility has partnered with eSSENTIAL Accessibility™ to provide you a specialized web browser at no charge. Individuals who have trouble typing, moving a mouse or reading can benefit from this assistive technology.

eSSENTIAL Accessibility™ provides an array of keyboard and mouse replacement solutions (i.e. alternative input methods) that help users to overcome physical limitations they may encounter while accessing the web. Features include a hands-free movement tracking system, onscreen keyboard with word prediction, a page reader and other customizable options. See the complete list of features.

This technology is suitable for those with dexterity challenges or reading difficulties arising from a variety of conditions, including: Stroke/paralysis, Arthritis, Multiple Sclerosis (MS), Parkinson's disease, Cerebral Palsy (CP), Age-related factors, Mild visual impairment, Limited proficiency in English, Literary deficiencies, Dyslexia, and Other learning issues.


Using a Mac?

Click here to learn about using
eSSENTIAL Accessibility on
an Apple computer.

Our organization is proud to be a member of this Disability Community Involvement initiative to create shared value. It reflects our commitment to diversity, inclusion, social responsibility and organizational values.

A man contacted his doctor’s office with concerns about a new medicine a specialist prescribed for him. The man stated that the medicine tasted bad and that he didn’t think he could take it.

Emily Jerry was just two years old when she died from a medication error made by a hospital pharmacy technician in Cleveland. She had undergone surgeries and four rounds of chemotherapy to treat what doctors said was a highly curable malignant tumor at the base of her spine.

Monday, 04 June 2012 20:48

Dangerous “toys”

On October 14, 2011, The New York Times published a story about a 13- month-old boy who died after swallowing pills from a prescription medicine bottle. His parents had given him the bottle to play with as a rattle, believing he could not open the child-resistant cap.

A nurse visited a homebound woman who continued to have high blood sugar levels despite doubling her insulin dose for about 2 weeks. The nurse questioned the woman about factors that may be causing the sudden need for more insulin. The woman had been eating her usual diet. She had no signs of infection or decrease in physical activity. She was sleeping well, and there was no new stress in her life. The technique and materials she used to test her blood sugar were appropriate. Any one of these factors could influence the dose of insulin required to keep her blood sugar under control, but nothing unusual was discovered.

FDA is warning consumers that a counterfeit version of Teva’s Adderall tablets contain the wrong active ingredients

We received a report from a woman whose child began having seizures while taking a shower. The family immediately called for help. Paramedics took the 11-year-old child to a nearby hospital to be examined. All scans and x-rays were negative. Doctors then ordered blood tests on the child. It was found that the child had an elevated blood alcohol level. This was most likely the cause of the child’s symptoms.

This list from FDA tells you what expired, unwanted, or unused medicines you should flush down the sink or toilet to help prevent danger to people and pets in the home. Flushing these medicines will get rid of them right away and help keep your family and pets safe.

FDA continually evaluates medicines for safety risks and will update the list as needed.


Active Ingredient

Abstral (PDF - 1M), tablets (sublingual)


Actiq (PDF - 251KB), oral transmucosal lozenge *

Fentanyl Citrate

Avinza (PDF - 51KB), capsules (extended release)

Morphine Sulfate

Buprenorphine Hydrochloride, tablets (sublingual) *

Buprenorphine Hydrochloride

Buprenorphine Hydrochloride; Naloxone Hydrochloride, tablets (sublingual) *

Buprenorphine Hydrochloride; Naloxone Hydrochloride

Butrans (PDF - 388KB), transdermal patch system


Daytrana (PDF - 281KB),transdermal patch system


Demerol, tablets *

Meperidine Hydrochloride

Demerol, oral solution *

Meperidine Hydrochloride

Diastat/Diastat AcuDial, rectal gel [for disposal
instructions: click on link, then go to "Label information"
and view current label] 


Dilaudid, tablets *

Hydromorphone Hydrochloride

Dilaudid, oral liquid *

Hydromorphone Hydrochloride

Dolophine Hydrochloride (PDF - 48KB), tablets *

Methadone Hydrochloride

Duragesic (PDF - 179KB), patch (extended release) *


Embeda (PDF - 39KB), capsules (extended release)

Morphine Sulfate; Naltrexone Hydrochloride

Exalgo (PDF - 83KB), tablets (extended release)

Hydromorphone Hydrochloride

Fentora (PDF - 338KB), tablets (buccal)

Fentanyl Citrate

Kadian (PDF - 135KB), capsules (extended release)

Morphine Sulfate

Methadone Hydrochloride, oral solution *

Methadone Hydrochloride

Methadose, tablets *

Methadone Hydrochloride

Morphine Sulfate, tablets (immediate release) *

Morphine Sulfate

Morphine Sulfate (PDF - 282KB), oral solution *

Morphine Sulfate

MS Contin (PDF - 433KB), tablets (extended release) *

Morphine Sulfate

Nucynta ER (PDF - 38KB), tablets (extended release)


Onsolis (PDF - 297KB), soluble film (buccal)

Fentanyl Citrate

Opana, tablets (immediate release)

Oxymorphone Hydrochloride

Opana ER (PDF - 56KB), tablets (extended release)

Oxymorphone Hydrochloride

Oxecta, tablets (immediate release)

Oxycodone Hydrochloride

Oxycodone Hydrochloride, capsules

Oxycodone Hydrochloride

Oxycodone Hydrochloride (PDF - 100KB), oral solution

Oxycodone Hydrochloride

Oxycontin (PDF - 417KB), tablets (extended release)

Oxycodone Hydrochloride

Percocet, tablets *

Acetaminophen; Oxycodone Hydrochloride

Percodan, tablets *

Aspirin; Oxycodone Hydrochloride

Suboxone (PDF - 83KB), film (sublingual)

Buprenorphine Hydrochloride; Naloxone Hydrochloride

Xyrem (PDF - 185KB), oral solution

Sodium Oxybate

Zubsolv (PDF - 354KB), tablets (sublingual)

Buprenorphine Hydrochloride; Naloxone Hydrochloride


*These medicines have generic versions available or are only available in generic formulations.

FDA continually evaluates medicines for safety risks and will update the list as needed.  

List revised: November 2013

1Consumers are advised to check their local laws and ordinances to make sure medicines can legally be disposed of with their household trash.

For specific drug product labeling information, go to DailyMed or Drugs@FDA.

Friday, 16 March 2012 00:00

Safety Labeling Changes

In March 2012, FDA required safety labeling changes to be made to 39 products, including five different drugs that now carry a warning that they should not be taken by pregnant women because of the risk of injury and death to the developing fetus.